Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh Radhakrishna

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapyDónal Michael McSweeney, Sophie Raby, Ganesh Radhakrishna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2018
Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?Nicola de Liguori Carino, Derek A O'Reilly, Ajith K Siriwardena, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Local radiotherapy polarized tumor-associated macrophages enhance the efficacy of Claudin18.2-targeted CAR-T therapy in pancreatic cancerXiaokang Zhang, Hongtai Shi, Leran Qiu, et al.
The Patient|December 28, 2020
Patient and Public Involvement Refines the Design of ProtOeus: A Proposed Phase II Trial of Proton Beam Therapy in Oesophageal CancerOwen J Nicholas, Olivier Joseph, Annie Keane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2020
SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancerDaniel L P Holyoake, Maxwell Robinson, Michael Silva, et al.
BJR Open|August 26, 2022
Online learning in proton radiation therapy: the future in the post-Covid-19 pandemic era?William Croxford, Anna France, Matthew Clarke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2016
Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancerDaniel L P Holyoake, Maxwell Robinson, Derek Grose, et al.
British Journal of Cancer|March 24, 2023
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort studyLewis A Hall, Siobhan C McKay, James Halle-Smith, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapyDónal Michael McSweeney, Sophie Raby, Ganesh Radhakrishna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2018
Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?Nicola de Liguori Carino, Derek A O'Reilly, Ajith K Siriwardena, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Local radiotherapy polarized tumor-associated macrophages enhance the efficacy of Claudin18.2-targeted CAR-T therapy in pancreatic cancerXiaokang Zhang, Hongtai Shi, Leran Qiu, et al.
The Patient|December 28, 2020
Patient and Public Involvement Refines the Design of ProtOeus: A Proposed Phase II Trial of Proton Beam Therapy in Oesophageal CancerOwen J Nicholas, Olivier Joseph, Annie Keane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2020
SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancerDaniel L P Holyoake, Maxwell Robinson, Michael Silva, et al.
BJR Open|August 26, 2022
Online learning in proton radiation therapy: the future in the post-Covid-19 pandemic era?William Croxford, Anna France, Matthew Clarke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2016
Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancerDaniel L P Holyoake, Maxwell Robinson, Derek Grose, et al.
British Journal of Cancer|March 24, 2023
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort studyLewis A Hall, Siobhan C McKay, James Halle-Smith, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Pageof 5